Data as of Sep 19
| -1.18 / -1.34%|
The 5 analysts offering 12-month price forecasts for GW Pharmaceuticals PLC have a median target of 110.00, with a high estimate of 147.00 and a low estimate of 83.69. The median estimate represents a +26.87% increase from the last price of 86.70.
The current consensus among 5 polled investment analysts is to Buy stock in GW Pharmaceuticals PLC. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.